Jonathan K. Embleton
Corporate Officer/Principal chez Amerigen Pharmaceuticals Ltd.
Profil
Jonathan K.
Embleton is a professional who has worked in various pharmaceutical companies.
He is currently the Chief Business Officer at Amerigen Pharmaceuticals Ltd.
Prior to this, he worked as a Vice President at Cardinal Health, Inc., a Principal at R.P.
Scherer Corp., and a Vice President-Product Ventures at Catalent Pharma Solutions, Inc. Embleton received his undergraduate and doctorate degrees from the University of Aston.
Postes actifs de Jonathan K. Embleton
| Sociétés | Poste | Début |
|---|---|---|
Amerigen Pharmaceuticals Ltd.
 Amerigen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Amerigen Pharmaceuticals Ltd. engages in the development, manufacturing, and sale of generic pharmaceutical products. The company was founded in 2007 and is headquartered in Lyndhurst, NJ. | Corporate Officer/Principal | 01/01/2010 |
Anciens postes connus de Jonathan K. Embleton
| Sociétés | Poste | Fin |
|---|---|---|
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | - |
| CATALENT PHARMA SOLUTIONS, INC. | Corporate Officer/Principal | - |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | - |
Formation de Jonathan K. Embleton
| University of Aston | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| Entreprise privées | 3 |
|---|---|
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Amerigen Pharmaceuticals Ltd.
Amerigen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Amerigen Pharmaceuticals Ltd. engages in the development, manufacturing, and sale of generic pharmaceutical products. The company was founded in 2007 and is headquartered in Lyndhurst, NJ. | Health Technology |
R.P. Scherer Corp.
 R.P. Scherer Corp. Pharmaceuticals: MajorHealth Technology R.P. Scherer Corp. Develops and manufactures oral drug delivery systems. The company offers different types of medical services and products. It has approximately 4 medical faculties in United States. The company is located in Troy, MI | Health Technology |
